Candid Health Raises $120 Million in Series D Funding
Candid Health, a San Francisco-based company specializing in healthcare revenue cycle software, has successfully raised $120 million in a Series D funding round. The round was led by Sixth Street Growth, with additional investments from Oak HC/FT, 8VC, and Y Combinator.
Company Overview
Candid Health provides software solutions that automate billing processes to increase net collections and accelerate cash flow for healthcare providers. By reducing manual work, the company aims to boost revenue and streamline the financial operations of healthcare organizations.
Leadership and Vision
The company was co-founded by Nick Perry, who serves as CEO, and Doug Proctor, who is the COO. "Our goal is to simplify and optimize the revenue cycle management for healthcare providers, allowing them to focus more on patient care," said Nick Perry.
Strategic Use of Funds
The newly acquired capital will be directed towards expanding Candid Health's technology offerings and supporting enterprise-level customers. The company plans to increase the integration of AI-driven tools across healthcare billing workflows, enhancing the automation of complex billing tasks.
Expanding the Platform
Candid Health's platform is designed to automate various revenue cycle management activities, including billing, claims processing, and collections. By consolidating clinical, billing, and provider information into a unified data model, the platform allows AI agents to perform tasks traditionally handled by billing teams. This not only reduces administrative costs but also minimizes lost collections due to inefficient legacy systems.
Market Impact
Operating across more than 200 healthcare organizations, Candid Health's platform addresses the substantial $280 billion annual market for healthcare revenue cycle management in the United States. The company has reported a 190% year-over-year growth in annual contracted run-rate revenue, highlighting the increasing demand for its services.
Outlook
With offices in San Francisco, New York, and Denver, Candid Health is well-positioned to continue its expansion and innovation in the healthcare revenue cycle management space. The Series D funding will enable the company to further enhance its platform, ensuring that healthcare providers can improve financial operations and focus more on delivering quality patient care.